About PeptideUnicorn
PeptideUnicorn is an editorially independent peptide research resource built by SUG Labs. We publish evidence-led coverage of peptide science, regulation, suppliers, and practical tools for readers across the US, UK, and Australia.
Our Mission
We exist to reduce confusion around peptides by making the evidence, legal context, and commercial landscape easier to understand. PeptideUnicorn is not a clinic, pharmacy, telehealth service, or healthcare provider.
Editorial Standards
- Every claim is backed by cited research or clearly labelled as preliminary
- Editorial content stays clearly separate from affiliate relationships
- Medical and regulatory content is reviewed and updated visibly
- Evidence grades are displayed where they help users interpret research strength
- Affiliate relationships and commercial intent are disclosed transparently
Our Team
Dr. Sarah Chen
MD, ABIM Board Certified
Chief Medical Reviewer
Board-certified internal medicine physician with 12 years of clinical experience. Specialises in integrative medicine and peptide therapy protocols. Medical advisor for several telehealth peptide clinics.
James Mitchell
MSc Biochemistry
Senior Editor & Researcher
Biochemistry researcher turned health journalist with 8 years covering peptide therapeutics, regulatory policy, and clinical research. Contributor to multiple peer-reviewed publications on peptide signalling pathways.
Built by SUG Labs
PeptideUnicorn is a product of SUG Labs. For business enquiries, partnership opportunities, or advertising, contact us at hello@peptideunicorn.com.